Indications and uses
Vol-Tab Rx is indicated for the supplemental requirements of patients with nutritional deficiencies or are in need of nutritional supplementation.
Vol-Tab Rx is indicated for the supplemental requirements of patients with nutritional deficiencies or are in need of nutritional supplementation.
One tablet daily, or as prescribed by a physician.
Rx Only
DESCRIPTION
Vol-Tab Rx is supplied as an oval, white tablet with "TL516" debossed on one side. Vol-Tab is an orally administered prescription vitamin for the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation.
| Supplement Facts | ||
| Servings per Bottle: 90 | ||
| Serving Size: 1 Tablet | %DV Adults and Children | |
| Each Tablet contains | 4 Years or More | |
| Folic Acid | 1 mg | 250% |
| Vitamin A (beta carotene) | 4000 IU | 80% |
| Vitamin D3 (cholecalciferol) | 400 IU | 100% |
| Vitamin E (dl-alpha-tocopheryl acetate) | 30 IU | 100% |
| Vitamin C (ascorbic acid) | 120 mg | 200% |
| Vitamin B1 (thiamine mononitrate) | 3 mg | 200% |
| Vitamin B2 (riboflavin) | 3 mg | 177% |
| Niacin (niacinamide) | 20 mg | 100% |
| Vitamin B6 (pyridoxine HCl) | 3 mg | 150% |
| Vitamin B12 (cyanocobalamin) | 8 mcg | 133% |
| Biotin | 30 mcg | 10% |
| Pantothenic Acid (calcium pantothenate) | 7 mg | 70% |
| Calcium (calcium carbonate) | 200 mg | 20% |
| Iodine (potassium iodide) | 150 mcg | 100% |
| Zinc (zinc oxide) | 15 mg | 100% |
| Magnesium (magnesium oxide) | 100 mg | 25% |
| Iron (carbonyl iron) | 29 mg | 161% |
| Copper (cupric oxide) | 3 mg | 150% |
Inactive Ingredients: Microcrystalline Cellulose, Coating (Hypromellose, Titanium Dioxide, Polyvinyl Alcohol, Polyethylene Glycol, Talc), Tripotassium Citrate, Acacia, Citric Acid, Croscarmellose Sodium, Povidone K30, Magnesium Stearate, Stearic Acid, Fumed Silica.
Vol-Tab Rx is indicated for the supplemental requirements of patients with nutritional deficiencies or are in need of nutritional supplementation.
This product is contraindicated in patients with known hypersensitivity to any of the ingredients.
| WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately. |
Folic acid, when prescribed as a single agent in doses above 0.1 mg daily, may obscure the detection of B12 deficiency (specifically, the administration of folic acid may reverse the hematological manifestations of B12 deficiency, including pernicious anemia, while not addressing the neurological manifestations). Reduced folates may be less likely than folic acid to mask vitamin B12 deficiency. Folate therapy alone is inadequate for the treatment of B12 deficiency.
Vol-Tab Rx is a prescription vitamin for use only under the direction and supervision of a licensed physician.
Pyridoxine hydrochloride should not be given to patients receiving the drug levodopa, because the action of levodopa is antagonized by pyridoxine hydrochloride. However, pyridoxine hydrochloride may be used concurrently in patients receiving a preparation containing both carbidopa and levodopa.
Drugs which may interact with folate include:
Allergic sensitization has been reported following both oral and parenteral administration of folic acid, as well as possibly the use of other forms of folates, including reduced folates. Paresthesia, somnolence, nausea and headaches have been reported with pyridoxine hydrochloride. Mild transient diarrhea, polycythemia vera, itching, transitory exanthema and the feeling of swelling of the entire body have been associated with cyanococobalamin.
One tablet daily, or as prescribed by a physician.
Vol-Tab Rx is dispensed in bottles of 90 tablets. PRODUCT CODE 13811-516-90
KEEP OUT OF REACH OF CHILDREN.
Rx Only
Manufactured for:
TRIGEN Laboratories, Inc., Sayreville, NJ 08872
www.trigenlab.com
Rev. 02/13
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .alpha.-tocopherol acetate, dl- | ACTIVE INGREDIENT | WR1WPI7EW8 | 1 | |
| .beta.-carotene | ACTIVE INGREDIENT | 01YAE03M7J | 1 | |
| ascorbic acid | ACTIVE INGREDIENT | PQ6CK8PD0R | 1 | |
| biotin | ACTIVE INGREDIENT | 6SO6U10H04 | 1 | |
| calcium carbonate | ACTIVE INGREDIENT | H0G9379FGK | 1 | |
| calcium pantothenate | ACTIVE INGREDIENT | 568ET80C3D | 1 | |
| cholecalciferol | ACTIVE INGREDIENT | 1C6V77QF41 | 1 | |
| cupric oxide | ACTIVE INGREDIENT | V1XJQ704R4 | 1 | |
| cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 1 | |
| Folic Acid | ACTIVE INGREDIENT | 935E97BOY8 | 1 | |
| iron pentacarbonyl | ACTIVE INGREDIENT | 6WQ62TAQ6Z | 1 | |
| magnesium oxide | ACTIVE INGREDIENT | 3A3U0GI71G | 1 | |
| niacinamide | ACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| potassium iodide | ACTIVE INGREDIENT | 1C4QK22F9J | 1 | |
| pyridoxine hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 1 | |
| riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 1 | |
| thiamine mononitrate | ACTIVE INGREDIENT | 8K0I04919X | 1 | |
| zinc oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| .alpha.-tocopherol, dl- | ACTIVE MOIETY | 7QWA1RIO01 | 1 | |
| .beta.-carotene | ACTIVE MOIETY | 01YAE03M7J | 1 | |
| ascorbic acid | ACTIVE MOIETY | PQ6CK8PD0R | 1 | |
| biotin | ACTIVE MOIETY | 6SO6U10H04 | 1 | |
| calcium cation | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| cholecalciferol | ACTIVE MOIETY | 1C6V77QF41 | 1 | |
| cupric cation | ACTIVE MOIETY | 8CBV67279L | 1 | |
| cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 1 | |
| Folic Acid | ACTIVE MOIETY | 935E97BOY8 | 1 | |
| iodide ion | ACTIVE MOIETY | 09G4I6V86Q | 1 | |
| iron pentacarbonyl | ACTIVE MOIETY | 6WQ62TAQ6Z | 1 | |
| magnesium cation | ACTIVE MOIETY | T6V3LHY838 | 1 | |
| niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 1 | |
| pantothenic acid | ACTIVE MOIETY | 19F5HK2737 | 1 | |
| pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 1 | |
| riboflavin | ACTIVE MOIETY | TLM2976OFR | 1 | |
| thiamine ion | ACTIVE MOIETY | 4ABT0J945J | 1 | |
| zinc oxide | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| acacia | INACTIVE INGREDIENT | 5C5403N26O | 1 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| croscarmellose sodium | INACTIVE INGREDIENT | M28OL1HH48 | 1 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| polyethylene glycols | INACTIVE INGREDIENT | 3WJQ0SDW1A | 1 | |
| polyvinyl alcohol | INACTIVE INGREDIENT | 532B59J990 | 1 | |
| potassium citrate anhydrous | INACTIVE INGREDIENT | 86R1NVR0HW | 1 | |
| povidone K30 | INACTIVE INGREDIENT | U725QWY32X | 1 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 13811-516 | 13811-516-30 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | WAFER / ORAL | 66 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TROCHE / ORAL | 315 mg | ||
| polyvinyl alcohol | POLYVINYL ALCOHOL | 532B59J990 | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION, EXTENDED RELEASE / ORAL | 71 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, FOR SUSPENSION / ORAL | 278 mg | ||
| polyvinyl alcohol | POLYVINYL ALCOHOL | 532B59J990 | SYSTEM / TOPICAL | 420 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 11 mg | ||
| acacia | ACACIA | 5C5403N26O | POWDER, FOR SUSPENSION / ORAL | 7386 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TROCHE / ORAL | 50 mg | ||
| talc | TALC | 7SEV7J4R1U | POWDER, FOR SUSPENSION / ORAL | 735 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, DELAYED RELEASE / ORAL | 66 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, FOR SUSPENSION / ORAL | 24 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | GRANULE / ORAL | 45 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 12 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | SOLUTION / TOPICAL | NA | ||
| polyvinyl alcohol | POLYVINYL ALCOHOL | 532B59J990 | AEROSOL, FOAM / VAGINAL | 0.5 %w/w | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, DELAYED RELEASE / ORAL | 72 mg | ||
| talc | TALC | 7SEV7J4R1U | GRANULE, DELAYED RELEASE / ORAL | 525 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | EMULSION / ORAL | NA | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | SUSPENSION, EXTENDED RELEASE / ORAL | 474 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 580 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / TOPICAL | 104 mg | ||
| acacia | ACACIA | 5C5403N26O | TABLET, EXTENDED RELEASE / ORAL | 34.4 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | CAPSULE, DELAYED RELEASE / ORAL | 227 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, COATED / ORAL | 320.75 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | POWDER / ORAL | 378 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / ORAL | 305 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | GRANULE, EFFERVESCENT / ORAL | 40 mg | ||
| talc | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | 176 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 144 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, LIQUID FILLED / ORAL | 12 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE / ORAL | 2169 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET / RECTAL | 32.4 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, COATED / ORAL | 224 mg | ||
| polyvinyl alcohol | POLYVINYL ALCOHOL | 532B59J990 | TABLET, EXTENDED RELEASE / ORAL | 96 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | SOLUTION / ORAL | 300 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | 100 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | SOLUTION / OPHTHALMIC | 42 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, DELAYED RELEASE / ORAL | 1060 mg | ||
| polyvinyl alcohol | POLYVINYL ALCOHOL | 532B59J990 | SUSPENSION / OPHTHALMIC | 1.4 %w/w | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | AEROSOL, FOAM / TOPICAL | 1.9 %w/w | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | TROCHE / ORAL | 175 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | PELLET / ORAL | 24 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, EXTENDED RELEASE / ORAL | 53 mg | ||
| talc | TALC | 7SEV7J4R1U | CAPSULE, COATED / ORAL | 87 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg | ||
| acacia | ACACIA | 5C5403N26O | TABLET, COATED / ORAL | 156 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Folic Acid | FOLIC ACID | REMEDYREPACK INC. | bda4687e-929a-434d-ab59-909cf2ed73a2 | 2026-09-11 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | REMEDYREPACK INC. | 368b69a8-a021-47e3-a6d7-e3497d7363b1 | 2026-09-04 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Rising Pharma Holdings, Inc. | 0baa10dd-6d1d-4946-8236-566451132da3 | 2026-07-24 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Northwind Health Company, LLC | 03b0aee4-804a-de63-e063-6394a90a6635 | 2026-07-13 | Warnings, Adverse reactions | FOLIC ACID |
| FOLIC ACID | FOLIC ACID | Unit Dose Solutions, Inc. | 54db8b21-87b9-5e0c-e063-6394a90ae8ea | 2026-06-22 | Warnings, Adverse reactions | FOLIC ACID |
| Vitramyn | FOLIC ACID | PureTek Corporation | c8af7616-5178-6df0-e053-2a95a90a334d | 2026-06-18 | Warnings, Adverse reactions | FOLIC ACID |
| FOLIC ACID | FOLIC ACID | Coupler LLC | 544e394d-3555-8ab1-e063-6394a90ade00 | 2026-06-15 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Major Pharmaceuticals | 7778ac96-7817-455a-a177-22ecb276c67f | 2026-05-26 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | QUAGEN PHARMACEUTICALS LLC | 354366ea-3702-4706-9fc0-0244b7278bd8 | 2026-05-20 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Cardinal Health 107, LLC | 624469a1-ded9-453a-973e-c5a2f0602bb0 | 2026-05-15 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Cardinal Health 107, LLC | 6dd867fe-597e-4915-8baf-98a605bf9324 | 2026-05-06 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Bryant Ranch Prepack | a1b71c5d-c842-43fd-9557-2bb4e934b914 | 2026-04-23 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Preferred Pharmaceuticals Inc. | b4c3a754-64cd-499a-a32f-a6e935c41355 | 2026-04-22 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Amneal Pharmaceuticals of New York LLC | fd85395e-6a0b-4072-a80b-36095c0c6dd6 | 2026-04-15 | Warnings, Adverse reactions | FOLIC ACID |
| Multitam | FOLIC ACID | PureTek Corporation | cee15842-4a9e-c6ba-e053-2a95a90aebc5 | 2026-04-13 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | XGen Pharmaceuticals DJB, Inc. | c5b2b84d-9f5e-4b81-ba10-9f2854e5dce9 | 2026-01-21 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Aphena Pharma Solutions - Tennessee, LLC | 40ab3c91-5a5b-fa1d-e063-6394a90a7454 | 2025-12-10 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | American Health Packaging | fc6dc1e1-f63e-4239-a1eb-67525569f68c | 2025-11-13 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Bryant Ranch Prepack | 4889d474-bd72-46ba-81d6-5511d8a85abb | 2025-11-04 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Bryant Ranch Prepack | 41914ac8-f4f5-4d70-b9f2-9f88c59d67a6 | 2025-10-29 | Warnings, Adverse reactions | FOLIC ACID |
Adverse event summaries are temporarily unavailable. Other product information remains available.